TNFAIP3 and neoplasm: Tumor regression was also found in anti-Gr1 antibody-treated mice while compared with the control group (Fig. 5b) and the mice treated with anti-Gr1 antibody also had improved T cell response (Fig. 5c), which was consistent with the changes in tumor volumes and immune responses in mice after the si-A20 treatment.